Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Xiawei Jiang in Pharmaceutical Science
Introduction
Xiawei Jiang is a notable inventor based in Zhejiang, China, who has made significant strides in the field of pharmaceutical science. With a focus on improving therapeutic options for patients, Jiang's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Jiang holds a patent for "Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof." This invention pertains to crystalline forms of a 5-HT receptor agonist known as lasmiditan, characterized by its advantages in crystallinity, hygroscopicity, morphology, crystal form stability, and chemical stability, compared to known forms. The invention includes preparation processes for these crystalline forms and their application in treating migraines and other conditions associated with 5-HT receptor dysfunction.
Career Highlights
Xiawei Jiang is affiliated with Hangzhou Solipharma Co., Ltd., where he utilizes his expertise to further pharmaceutical developments. His contribution to the patent landscape not only reflects his innovative thinking but also highlights a commitment to enhancing patient care through effective medication.
Collaborations
Throughout his career, Jiang has collaborated with notable colleagues such as Xiaohong Sheng and Xiaoxia Sheng. These partnerships have facilitated the advancement of his research and the successful development of pharmaceutical formulations, showcasing the importance of teamwork in the innovation process.
Conclusion
Xiawei Jiang's inventive work in the realm of crystalline pharmaceutical compounds marks a pivotal step in addressing medical conditions that affect many individuals globally. His dedication to improving existing treatments embodies the spirit of innovation, paving the way for future advancements in pharmaceuticals.